SE
50
-5
CB
50
4
NWS
83
4
LUV
45
2
ESS
65
5
USB
53
3
ZTS
47
7
MMM
44
2
BRK.B
40
2
INTU
60
2
TXT
66
-3
AAP
30
-3
AVGO
42
-2
URI
72
3
GPC
37
2
IR
71
-4
PAYX
60
3
PHM
63
4
FMC
41
-3
PYPL
52
2
SE
50
-5
CB
50
4
NWS
83
4
LUV
45
2
ESS
65
5
USB
53
3
ZTS
47
7
MMM
44
2
BRK.B
40
2
INTU
60
2
TXT
66
-3
AAP
30
-3
AVGO
42
-2
URI
72
3
GPC
37
2
IR
71
-4
PAYX
60
3
PHM
63
4
FMC
41
-3
PYPL
52
2
Financhill
Back

Materialise NV 10K Form

Buy
67

MTLS
Materialise NV

Last Price:
6.71
Seasonality Move:
7.53%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive MTLS News And Ratings

See the #1 stock for the next 7 days that we like better than MTLS

MTLS Financial Statistics

Sales & Book Value

Annual Sales: $277.29M
Cash Flow: $-341.5K
Price / Cash Flow: 83.16
Annual Sales: $4.67
Price / Book: 1.44

Profitability

EPS (TTM): 0.18480
Net Income (TTM): $11.15M
Gross Margin: $157.12M
Return on Equity: 4.27%
Return on Assets: 2.6%

Materialise NV Earnings Forecast

Key Materialise NV Financial Ratios

  • The Gross Profit Margin over the past 12 years for MTLS is 56.66%.
  • The Selling, General & Administrative Expenses for MTLS have been equal to 35.23% of Gross Profit Margin.
  • The Research & Development expenses have been 14.87% of Revenue.
  • The Interest Expense is 26.05% of Operating Income.
  • The Net Earning history of MTLS is 2.62% of Total Revenues.
  • Per Share Earnings over the last 12 years have been positive in 5 years.

Materialise NV Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Software
Sector: Information Technology
Current Symbol: MTLS
CUSIP: 57667T
Website: materialise.com

Debt

Debt-to-Equity Ratio: 0.18
Current Ratio: 1.81
Quick Ratio: 1.54

Price-to-Earnings

Trailing P/E Ratio: 56.43
Forward P/E Ratio: 23.28

MTLS Technical Analysis vs Fundamental Analysis

Buy
67
Materialise NV (MTLS) is a Buy

Is Materialise NV a Buy or a Sell?

  • Materialise NV stock is rated a Buy
    The current Materialise NV [MTLS] share price is $6.72. The Score for MTLS is 67, which is 34% above its historic median score of 50, and infers lower risk than normal.